
Honeycomb Investment Trust plc – Annual Report and Audited Financial Statements 2021 35
GOING CONCERN
The Directors have reviewed the financial projections of the
Group from the date of this report, which shows that the Group
will be able to generate sufficient cash flows in order to meet
its liabilities as they fall due. These financial projections have
been performed for Honeycomb under various origination
volumes and stressed scenarios and in all cases the Group is
able to meet its liabilities as they fall due. The stressed
scenarios considered included halting future originations, late
repayments of the largest structured facilities and individual
exposures experiencing ongoing performance at the worst
monthly impact experienced throughout 2020 and 2021; which
incorporated one-off macro-economic charges for Covid-19.
The Directors consider these scenarios to be the most relevant
risks to the Group’s operations. As part of these projections, the
Directors have also reviewed any financial and non-financial
covenants in place for all debt facilities with no breaches
anticipated, even in the stressed scenario.
The Directors have also reviewed the potential effect of the
combination with Pollen Street on financial projections of the
combined group. These financial projections have been stress
tested under different scenarios, including delaying all
additional fund raises to demonstrate that the combined
group will be able to generate sufficient cash flows in order to
meet its liabilities as they fall due.
The Group has performed these prudent financial scenarios to
ensure that it has sufficient cash resources to weather any
remaining impact of Covid-19, as it continues to cause
disruption across the globe. The conclusion of the stress
testing is that the business has more than adequate cash
resources, including under the proposed combination with
Pollen Street, to meet its liabilities as they fall due over the next
12 months from the date of approval of these financial
statements being the 1 March 2022.
Accordingly, the Directors are satisfied that the going concern
basis remains appropriate for the preparation of the financial
statements. The Group also has detailed policies and
processes for managing the risk, set out in the Strategic Report
on pages 25 to 28.
VIABILITY STATEMENT
In accordance with provision 31 of the UK Corporate
Governance Code, published by the Financial Reporting
Council in 2018 (the “Code”) and the corresponding provision
36 of The AIC Code of Corporate Governance (the “AIC Code”),
the Directors have assessed the prospects of the Group over
the three-year period to the AGM in 2025. The Board believes
this period to be appropriate taking into account the current
trading position and the potential impact of the principal risks
that could affect the viability of the Group.
At the year-end, the Group had cash balances of £12.9 million.
The Company also has £396 million excess of non-current
assets to non-current liabilities. There are therefore limited
risks to the viability of the Company.
To prepare the viability statement the Board have considered
the prospects of the Company in light of its current position
and have considered each of the Company’s principal risks,
uncertainties and mitigating factors that are detailed on pages
25 to 28. Taking the current performance as a base, the
projection considers the Company’s income, underlying Net
Asset Value and the cash flows over the three-year period
selected. In addition, the Board have reviewed the potential
effect of the combination with Pollen Street. The projection is
not a business plan in itself, but rather is a prudent view of how
the Company may evolve, based principally upon its growth to
date, in order to demonstrate its viability. Analysis to assess
viability has focused on the risks in delivery of the growth of the
business and a series of projections have been considered
changing origination volumes and the performance of the
assets acquired.
The experience of Covid-19 over 2020 and 2021 has been
considered in these projections as part of the stress testing in
the going concern analysis which has also been used as part of
the analysis for the Company’s viability. In this case the Group
continues to be viable, though with the prospect of the
continued vaccine ‘booster’ rollout in the UK, and around the
globe, the Directors expect the actual impact to be more
favourable than the levels projected.
All the analysis indicates that due to the stability and cash
generating nature of the portfolios and structured agreements,
as well as the debt facilities in place, the Company would be
able to withstand the impact of the risks identified, including
under the proposed combination with Pollen Street. Based on
the robust assessment of the principal risks, prospects and
viability of the Company, the Board confirms that they have
reasonable expectation that the Company will be able to
continue operation and meet its liabilities as they fall due over
the three-year period to the AGM in 2025. The Board also
continuously monitors the financial performance of the
Company against key financial ratios ensuring a strict discipline
in the financial management of the business.
CAPITAL RE QUIREMENTS
The Group is subject to externally imposed capital
requirements:
The Company’s Articles of Association restrict
borrowings to the value of its share capital and
reserves;
As a public company, the Company has a minimum
share capital of £50,000;
To be able to pay dividends out of profits available for
distribution by way of dividends, the Company must be
able to meet one of the two capital restriction tests
imposed on investment companies by company law;
and